ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

PeopleandPicks.com is Zacks' Community Website
Find great stocks and great stock pickers in our online community. It's social, it's profitable and it's Free! Join the fun at PeopleandPicks.com

Quote:

Search for Ticker

Free Membership

Search:

HITK: Hi-tech Pharmacal Co Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

HI-TECH PHARMACAL CO INC (NASD)
HITK	20.46	0.28	(1.39%)	Vol. 186,196	16:00 ET

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing branded and generic products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace.

General Information

HI TECH PHARMA

369 Bayview Avenue Amityville, NY 11701 Phone: 631 789-8228 Fax: 631 789-8429 Web: www.hitechpharm.com Email: None

Industry	MED-GENERIC DRG
Sector:	Medical

Fiscal Year End	April
Last Reported Quarter	01/31/10
Next EPS Date	03/10/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	20.18
52 Week High	29.89
52 Week Low	4.50
Beta	1.51
20 Day Moving Average	384,550.19
Target Price Consensus	23

% Price Change
4 Week	-30.39
12 Week	-0.10
YTD	-28.06

% Price Change Relative to S&P 500
4 Week	-25.11
12 Week	3.94
YTD	-24.12

Share Information
Shares Outstanding (millions)	12.08
Market Capitalization (millions)	243.82
Short Ratio	2.59
Last Split Date	01/12/2006

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.50
Current Year EPS Consensus Estimate	2.27
Estimated Long-Term EPS Growth Rate	-
Next EPS Report Date	03/10/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	4.00
30 Days Ago	3.50
60 Days Ago	3.00
90 Days Ago	3.00

Fundamental Ratios

P/E
Current FY Estimate:	8.89
Trailing 12 Months:	11.21
PEG Ratio	-

EPS Growth
vs. Previous Year	566.67%
vs. Previous Quarter	-1.64%

Sales Growth
vs. Previous Year	62.69%
vs. Previous Quarter:	-5.98%

Price Ratios
Price/Book	2.10
Price/Cash Flow	17.65
Price / Sales	-

ROE
01/31/10	-
10/31/09	22.81
07/31/09	17.83

ROA
01/31/10	-
10/31/09	18.43
07/31/09	14.37

Current Ratio
01/31/10	-
10/31/09	4.95
07/31/09	3.47

Quick Ratio
01/31/10	-
10/31/09	3.91
07/31/09	2.72

Operating Margin
01/31/10	-
10/31/09	14.12
07/31/09	11.15

Net Margin
01/31/10	-
10/31/09	23.89
07/31/09	20.48

Pre-Tax Margin
01/31/10	-
10/31/09	23.89
07/31/09	20.48

Book Value
01/31/10	-
10/31/09	9.63
07/31/09	8.46

Inventory Turnover
01/31/10	-
10/31/09	3.66
07/31/09	3.32

Debt-to-Equity
01/31/10	-
10/31/09	0.00
07/31/09	0.00

Debt to Capital
01/31/10	-
10/31/09	0.11
07/31/09	0.19


About Zacks \| Advertise \| Affiliate \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2010 Zacks Investment Research